-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Initiates Coverage On PROCEPT BioRobotics with Overweight Rating, Announces Price Target of $30

Benzinga·10/07/2026 13:05:31
Listen to the news
Barclays analyst Christopher Pasquale initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight rating and announces Price Target of $30.